WideCells Group PLC Celebrates its Five-Year Anniversary

WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, is delighted to announce its five-year anniversary today.
WideCells Group was established in order to transform the stem cell industry by creating the first end-to-end service solutions to make stem cell treatment accessible and affordable globally.  Having recognised a need and identified an opportunity to change the way in which stem cell services are provided globally, Chief Executive Officer João Andrade and Chief Operating Officer Lopes Gil founded the company.  Since its inception, WideCells Group has made formidable progress in creating a dynamic, revenue generative business, which is now listed on the London Stock Exchange.   The significant progress made by the Group has resulted in WideCells Group being ranked as the 21st most disruptive company globally by DISRUPT 100 and being nominated as the Life Sciences IPO of the Year 2016 by Biotech & Money.

The Group’s service offering spans three synergistic divisions:

CellPlan Limited has successfully created and launched the world’s first stem cell healthcare insurance plan – CellPlan.  Recognising that whilst over 3 million people worldwide have paid c.£2,000 to store stem cells, the Group discovered that many were unaware that the cost to use stem cells in treatment can be up to £300,000.  Accordingly, the Group set out to remove cost barriers by creating CellPlan, which for an average price of £170 per annum provides financial cover for medical treatment, travel and accommodation expenses, an expert medical opinion and a concierge service to manage the stem cell treatment process.  The product is now available for purchase in the UK having secured strategic commercial agreements with the UK’s largest private human tissue storage facility Biovault Technical Ltd (‘Biovault’).  The Company is also due to launch an e-commerce platform shortly and has signed an agreement to supply customers in Brazil via Hemocord Clinica Medica Ltd, a world-class leader in cord blood storage.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Umbilical blood injects new life into 8-month-old baby

    An 8-month-old girl who had severe combined immune deficiency (SCID) underwent a successful hematopoietic stem cell transplant surgery in Shanghai. The stem cell was taken from umbilical cord blood. Widecells Group PLC (LON:WDC) are leading a

    WideCells Group PLC

    Leukaemia: A Guide To The Cancer Of The Blood

    It is not hereditary, and it is not contagious. It is, however, one of the diseases that kills more children than many others. The word ‘leukaemia’ refers to a group of cancers that spread through the

    WideCells Group PLC

    Autism Treated With Stem Cells

    Researchers at Duke University have utilized autologous (the patient’s own) stem cell infusions to promote increased connectivity in the brain that allowed for improved communication and language abilities in children with Autism Spectrum Disorder (ASD). The

    WideCells Group PLC

    Cord blood banking industry expected to grow

    The list of decisions for new parents already seems endless but it continues to grow as new advances in medicine and technology open new doors for healthcare. Many private companies offer services for collecting and storing